SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Impath Inc. (IMPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: stockid who wrote (37)2/16/1998 7:09:00 PM
From: Dr.Hamma  Read Replies (3) of 68
 
SK & all,

I lifted the following from the Yahoo message board.

<<Impath is in a very crucial business.. developing treatment plans
for those with cancer. One "added value" is the ability to create tailored plans for patients with a 48 hour turnaround. No one else does that. If you know anyone who has been through cancer therapy you can appreciate what they bring to market. Their other "added value" is their patient database; over 200,000 cases at last count. They are developing a software system to allow doctors and big pharmaceutical companies access to the database for a fee. I talked to Iris Daniels last week about why they're raising 2M shares (about $68M at current prices). Its to rollout their software system in 2H98. This is going to explode.>>

Any thoughts?

DH
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext